Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.62
-0.15 (-2.22%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Eupraxia Pharmaceuticals Employees
Eupraxia Pharmaceuticals had 49 employees as of December 31, 2025. The number of employees increased by 16 or 48.48% compared to the previous year.
Employees
49
Change (1Y)
16
Growth (1Y)
48.48%
Revenue / Employee
n/a
Profits / Employee
-$1,075,046
Market Cap
435.64M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 49 | 16 | 48.48% | 49 | 0 |
| Dec 31, 2024 | 33 | 4 | 13.79% | 33 | 0 |
| Dec 31, 2023 | 29 | 8 | 38.10% | 29 | 0 |
| Dec 31, 2022 | 21 | 0 | - | 21 | 0 |
| Dec 31, 2021 | 21 | 9 | 75.00% | 19 | 2 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| REGENXBIO | 371 |
| Arvinas | 246 |
| Allogene Therapeutics | 152 |
| MapLight Therapeutics | 133 |
| Prothena Corporation | 67 |
| Oculis Holding AG | 60 |
| Altimmune | 57 |
EPRX News
- 2 days ago - Eupraxia Pharmaceuticals reaches enrollment target for RESOLVE study - TheFly
- 2 days ago - Eupraxia Pharmaceuticals Reaches its Enrollment Target for the RESOLVE Trial Investigating EP-104GI for the Treatment of Eosinophilic Esophagitis - GlobeNewsWire
- 8 days ago - Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences - GlobeNewsWire
- 17 days ago - Eupraxia announces data from Phase 1b/2a RESOLVE study of EP-104GI - TheFly
- 17 days ago - Eupraxia Pharmaceuticals Reports 52-Week Data from the Highest Dose Cohort of EP-104GI in its Ongoing Phase 1b/2a RESOLVE Trial for the Treatment of Eosinophilic Esophagitis - GlobeNewsWire
- 23 days ago - Wedbush bullish on Eupraxia Pharmaceuticals, initiates with an Outperform - TheFly
- 23 days ago - Eupraxia Pharmaceuticals initiated with an Outperform at Wedbush - TheFly
- 4 weeks ago - Eupraxia Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts